Avalon Pharma at CPhI Madrid (9-11 October 2018)
Updated: Feb 28
As part of its commitment to expanding its global reach, Avalon Pharma exhibited its range of export products at CPhI Madrid (9-11 October, 2018).
Mr. Maher Ghannam, the CEO of Avalon Pharma and Mr. Khaled Abu Rub, the company's Finance Director and other members of Avalon Pharma's export team were on hand to meet with existing and potential distributors and strategic partners from around the world; sharing with them the brand's wide range of products, its commitment to quality and its vision of delivering health and wellbeing.
Mr. Maher Ghannam commented, "We are very proud to showcase the pharmaceutical manufacturing capabilities of our Saudi Arabian company. Our commitment towards Vision2030 and towards representing the best that the Kingdom has to offer, is second to none!" In regard to the exhibition, Mr. Ghannam added, "CPhI is the world’s largest pharmaceutical exhibition, housing six individual pharma events covering all industry sectors, from ingredients and FDF, to machinery, packaging, outsourcing and biopharmaceuticals. With over 45,000 pharma professionals from around the globe and more than 2,500 international exhibitors, it is a great opportunity for us to showcase our products, our vision and our desire to expand our global reach."